Tumour lysis syndrome in haematological malignancies

Fauzia Wasim, Abdul Manan Khaskheli, Aftab Ahmed Siddiqui, Osama Tariq, Moin Ahmed Ansari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: This study was conducted to determine the frequency of tumor lysis syndrome (TLS) in haematological malignancies. Materials and Methods: This descriptive study was conducted at Liaquat National Postgraduate Medical Centre from October 2005 to April 2006 over a period of six months. Total 50 patients with diagnosed haematological malignancies were included in the study and data were collected by non-probability convenient sampling. Patients pretreated for their malignancy were excluded from the study. Venous samples for serum uric acid, LDH, phosphorus, calcium, potassium and creatinine were collected on admission, before starting chemotherapy and then for four days after starting the chemotherapy. All patients received adequate hydration, allopurinol and induction chemotherapy. Data were analysed by statistical package for social sciences (SPSS) version16.0. Results: Out of 50 patients 10 fulfilled the criteria for TLS. Six patients developed laboratory tumor lysis syndrome (LTLS), whereas 4 developed clinical tumourlysis syndrome.Acute renal failure was observed in 4 out of 10 patients. Overall 3 patients died because of TLS. Hyperuricaemia and lactate dehydrogenase above 2000 IU were the most prominent findings in patients with TLS. Conclusion: It is concluded that 20% of the patients developed TLS (including both laboratory and clinical TLS and despite all measures of prevention it can occur and result in devastating clinical effects.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalJournal of the Liaquat University of Medical and Health Sciences
Volume11
Issue number2
Publication statusPublished - May 2012

Fingerprint

Tumor Lysis Syndrome
Hematologic Neoplasms
Drug Therapy
Allopurinol
Induction Chemotherapy
Social Sciences
Uric Acid
L-Lactate Dehydrogenase
Acute Kidney Injury
Phosphorus
Creatinine
Potassium
Calcium

Keywords

  • Acute renal failure
  • Hyperphosphataemia
  • Hyperuricaemia
  • Hypocalcaemia
  • Tumor lysis syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tumour lysis syndrome in haematological malignancies. / Wasim, Fauzia; Khaskheli, Abdul Manan; Siddiqui, Aftab Ahmed; Tariq, Osama; Ansari, Moin Ahmed.

In: Journal of the Liaquat University of Medical and Health Sciences, Vol. 11, No. 2, 05.2012, p. 84-89.

Research output: Contribution to journalArticle

Wasim, Fauzia ; Khaskheli, Abdul Manan ; Siddiqui, Aftab Ahmed ; Tariq, Osama ; Ansari, Moin Ahmed. / Tumour lysis syndrome in haematological malignancies. In: Journal of the Liaquat University of Medical and Health Sciences. 2012 ; Vol. 11, No. 2. pp. 84-89.
@article{784eda6f2a1b4b5a8b49bf1662d75213,
title = "Tumour lysis syndrome in haematological malignancies",
abstract = "Objectives: This study was conducted to determine the frequency of tumor lysis syndrome (TLS) in haematological malignancies. Materials and Methods: This descriptive study was conducted at Liaquat National Postgraduate Medical Centre from October 2005 to April 2006 over a period of six months. Total 50 patients with diagnosed haematological malignancies were included in the study and data were collected by non-probability convenient sampling. Patients pretreated for their malignancy were excluded from the study. Venous samples for serum uric acid, LDH, phosphorus, calcium, potassium and creatinine were collected on admission, before starting chemotherapy and then for four days after starting the chemotherapy. All patients received adequate hydration, allopurinol and induction chemotherapy. Data were analysed by statistical package for social sciences (SPSS) version16.0. Results: Out of 50 patients 10 fulfilled the criteria for TLS. Six patients developed laboratory tumor lysis syndrome (LTLS), whereas 4 developed clinical tumourlysis syndrome.Acute renal failure was observed in 4 out of 10 patients. Overall 3 patients died because of TLS. Hyperuricaemia and lactate dehydrogenase above 2000 IU were the most prominent findings in patients with TLS. Conclusion: It is concluded that 20{\%} of the patients developed TLS (including both laboratory and clinical TLS and despite all measures of prevention it can occur and result in devastating clinical effects.",
keywords = "Acute renal failure, Hyperphosphataemia, Hyperuricaemia, Hypocalcaemia, Tumor lysis syndrome",
author = "Fauzia Wasim and Khaskheli, {Abdul Manan} and Siddiqui, {Aftab Ahmed} and Osama Tariq and Ansari, {Moin Ahmed}",
year = "2012",
month = "5",
language = "English",
volume = "11",
pages = "84--89",
journal = "Journal of the Liaquat University of Medical and Health Sciences",
issn = "1729-0341",
publisher = "Liaquat University of Medical and Health Sciences",
number = "2",

}

TY - JOUR

T1 - Tumour lysis syndrome in haematological malignancies

AU - Wasim, Fauzia

AU - Khaskheli, Abdul Manan

AU - Siddiqui, Aftab Ahmed

AU - Tariq, Osama

AU - Ansari, Moin Ahmed

PY - 2012/5

Y1 - 2012/5

N2 - Objectives: This study was conducted to determine the frequency of tumor lysis syndrome (TLS) in haematological malignancies. Materials and Methods: This descriptive study was conducted at Liaquat National Postgraduate Medical Centre from October 2005 to April 2006 over a period of six months. Total 50 patients with diagnosed haematological malignancies were included in the study and data were collected by non-probability convenient sampling. Patients pretreated for their malignancy were excluded from the study. Venous samples for serum uric acid, LDH, phosphorus, calcium, potassium and creatinine were collected on admission, before starting chemotherapy and then for four days after starting the chemotherapy. All patients received adequate hydration, allopurinol and induction chemotherapy. Data were analysed by statistical package for social sciences (SPSS) version16.0. Results: Out of 50 patients 10 fulfilled the criteria for TLS. Six patients developed laboratory tumor lysis syndrome (LTLS), whereas 4 developed clinical tumourlysis syndrome.Acute renal failure was observed in 4 out of 10 patients. Overall 3 patients died because of TLS. Hyperuricaemia and lactate dehydrogenase above 2000 IU were the most prominent findings in patients with TLS. Conclusion: It is concluded that 20% of the patients developed TLS (including both laboratory and clinical TLS and despite all measures of prevention it can occur and result in devastating clinical effects.

AB - Objectives: This study was conducted to determine the frequency of tumor lysis syndrome (TLS) in haematological malignancies. Materials and Methods: This descriptive study was conducted at Liaquat National Postgraduate Medical Centre from October 2005 to April 2006 over a period of six months. Total 50 patients with diagnosed haematological malignancies were included in the study and data were collected by non-probability convenient sampling. Patients pretreated for their malignancy were excluded from the study. Venous samples for serum uric acid, LDH, phosphorus, calcium, potassium and creatinine were collected on admission, before starting chemotherapy and then for four days after starting the chemotherapy. All patients received adequate hydration, allopurinol and induction chemotherapy. Data were analysed by statistical package for social sciences (SPSS) version16.0. Results: Out of 50 patients 10 fulfilled the criteria for TLS. Six patients developed laboratory tumor lysis syndrome (LTLS), whereas 4 developed clinical tumourlysis syndrome.Acute renal failure was observed in 4 out of 10 patients. Overall 3 patients died because of TLS. Hyperuricaemia and lactate dehydrogenase above 2000 IU were the most prominent findings in patients with TLS. Conclusion: It is concluded that 20% of the patients developed TLS (including both laboratory and clinical TLS and despite all measures of prevention it can occur and result in devastating clinical effects.

KW - Acute renal failure

KW - Hyperphosphataemia

KW - Hyperuricaemia

KW - Hypocalcaemia

KW - Tumor lysis syndrome

UR - http://www.scopus.com/inward/record.url?scp=84867690895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867690895&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 84

EP - 89

JO - Journal of the Liaquat University of Medical and Health Sciences

JF - Journal of the Liaquat University of Medical and Health Sciences

SN - 1729-0341

IS - 2

ER -